1
|
Moazen B, Ismail N, Agbaria N, Mazzilli S, Petri D, Amaya A, D’Arcy J, Plugge E, Tavoschi L, Stöver H. Vaccination against emerging and reemerging infectious diseases in places of detention: a global multistage scoping review. Front Public Health 2024; 12:1323195. [PMID: 38347924 PMCID: PMC10859397 DOI: 10.3389/fpubh.2024.1323195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Accepted: 01/04/2024] [Indexed: 02/15/2024] Open
Abstract
Background Despite the elevated risks of infection transmission, people in prisons frequently encounter significant barriers in accessing essential healthcare services in many countries. The present scoping review aimed to evaluate the state of availability and model of delivery of vaccination services within correctional facilities across the globe. Methods Following the methodological framework for scoping reviews and adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews criteria, we conducted a systematic search across four peer-reviewed literature databases (Medline via PubMed, Web of Science, the Cochrane Library, Science Direct, and EBSCO), as well as 14 sources of grey literature. Two researchers meticulously examined the identified papers independently to extract pertinent data published between 2012 and 2022. The quality of the selected publications was assessed using established quality assessment tools. Results Of the 11,281 identified papers 52 met the inclusion criteria. With the exception of one, all the included publications presented data from high-income countries, predominantly originating from the United States. Across the world, the most prevalent vaccines available in prison settings were COVID-19 and HBV vaccines, typically distributed in response to health crises such as pandemics, epidemics, and local outbreaks. Vaccine coverage and uptake rates within correctional facilities displayed noteworthy disparities among various countries and regions. Besides, individual and organizational barriers and facilitating factors of vaccination in prison settings emerged and discussed in the text. Discussion The lack of vaccination services combined with low rates of vaccination coverage and uptake among people living and working in correctional facilities represents a cause for concern. Prisons are not isolated from the broader community, therefore, efforts to increase vaccine uptake among people who live and work in prisons will yield broader public health benefits.
Collapse
Affiliation(s)
- Babak Moazen
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
- Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt, Germany
| | - Nasrul Ismail
- School for Policy Studies, University of Bristol, Bristol, United Kingdom
| | - Nisreen Agbaria
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
- Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt, Germany
| | - Sara Mazzilli
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - Davide Petri
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - Arianna Amaya
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
| | | | - Emma Plugge
- UK Health Security Agency, London, United Kingdom
- Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| | - Lara Tavoschi
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - Heino Stöver
- Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt, Germany
| |
Collapse
|
2
|
Lipnicky A, Stites S, Sufrin C, Bello JK, Shlafer R, Kelly PJ, Ramaswamy M. Jail Provision of Pregnancy and Sexual Health Services in Four Midwestern States. Womens Health Issues 2023; 33:97-104. [PMID: 36096980 DOI: 10.1016/j.whi.2022.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Revised: 07/10/2022] [Accepted: 07/21/2022] [Indexed: 02/01/2023]
Abstract
OBJECTIVE Women incarcerated in local jails have pregnancy and sexual health needs, yet little information is available about what services are provided and how jail administrators prioritize this care. Our objective was to document jails' provision of pregnancy and sexual health services in four states in the Midwest. METHODS We invited all jail administrators (N = 347) in Kansas, Missouri, Iowa, and Nebraska to participate in a web-based survey conducted from November 2017 to October 2018. We asked administrators which pregnancy and sexual health services they offered and to rate the importance of offering services. Results were analyzed using descriptive statistics and logistic regression. RESULTS The survey response rate was 55% (192/347). Jails most often provided pregnancy testing (n = 116 [60%]) and distribution of prenatal vitamins (n = 85 [44%]). Sexually transmitted infection treatment was offered at 23% of jails (n = 45). Larger, accredited jails located in urban areas and with high numbers of clinical providers on staff were more likely to provide sexual health services. Jails with privately contracted health care were more likely to provide pregnancy services compared with other entities providing medical care. The most prioritized sexual health service was sexually transmitted infection testing, with 39% of administrators believing it was important. Only 6% of administrators responded that contraception was important. CONCLUSIONS Local jails in the Midwest do not meet the basic reproductive and sexual health needs of women. Provision of these services is not a priority for jail administrators. Appropriate partnerships could engage administrators and increase the availability of services to meet the needs of women in jail.
Collapse
Affiliation(s)
- Ashlyn Lipnicky
- University of Kansas School of Medicine, Kansas City, Kansas
| | - Sierra Stites
- University of Kansas School of Medicine, Kansas City, Kansas
| | | | | | - Rebecca Shlafer
- University of Minnesota Medical School, Minneapolis, Minnesota
| | | | - Megha Ramaswamy
- University of Kansas School of Medicine, Kansas City, Kansas
| |
Collapse
|
3
|
Ramaswamy M, Satterwhite CL, Lipnicky A, Emerson A, Griffin P, Ash D, Ault K. Recommendations for Delivering COVID-19 Vaccine in Jails: Evidence from Kansas, Iowa, Nebraska, and Missouri. Am J Public Health 2021; 111:1035-1039. [PMID: 33950714 DOI: 10.2105/ajph.2021.306218] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
We report on data we collected from a 2018 survey examining jails' human papillomavirus virus vaccine delivery capacity and on a secondary analysis we conducted to describe factors similarly associated with delivery planning for the COVID-19 vaccine. We provide recommendations for delivering the COVID-19 vaccine in jails, based on evidence from Kansas, Iowa, Nebraska, and Missouri. Our key finding is that jails have limited staff to implement vaccination and will require collaboration between jail administrators, jail medical staff, and local health departments.
Collapse
Affiliation(s)
- Megha Ramaswamy
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Catherine L Satterwhite
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Ashlyn Lipnicky
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Amanda Emerson
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Phil Griffin
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Donald Ash
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| | - Kevin Ault
- Megha Ramaswamy, Ashlyn Lipnicky, and Kevin Ault are with the University of Kansas Medical Center, Kansas City. Catherine L. Satterwhite is with the Office of the Assistant Secretary for Health, US Department of Health and Human Services, Kansas City, MO. Amanda Emerson is with the School of Nursing and Health Studies, University of Missouri-Kansas City. Phil Griffin is with the Bureau of Disease Control and Prevention, Kansas Department of Health and Environment, Topeka. Donald Ash is with the Wyandotte County, Kansas Sheriff's Office, Kansas City, KS
| |
Collapse
|
4
|
Emerson A, Allison M, Saldana L, Kelly PJ, Ramaswamy M. Collaborating to offer HPV vaccinations in jails: results from a pre-implementation study in four states. BMC Health Serv Res 2021; 21:309. [PMID: 33827560 PMCID: PMC8028758 DOI: 10.1186/s12913-021-06315-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2020] [Accepted: 03/24/2021] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND Correctional facilities are an underutilized venue for reaching young adults who have not vaccinated for human papillomavirus (HPV). The objective of this study was to identify factors that are associated with jail and local health department (LHD) interest in partnering to offer HPV vaccinations to young adults in jail. METHODS Consolidated framework for implementation research (CFIR)-guided surveys were conducted with jail administrators in Iowa, Kansas, Missouri, and Nebraska, September 2017-October 2018. Jail survey data were analyzed using chi square distribution and relative risk regression. Using data from sister surveys conducted with LHD administrators in the same counties (results previously reported), we identified characteristics of counties in which both the jail and LHD indicated interest in collaborating to offer HPV vaccinations in the jail. RESULTS Jail survey response was 192/347 (55.3%). Surveys with LHDs yielded 237/344 (68.9%) responses. Eleven communities were identified where both the jail and LHD expressed interest. Only "any vaccines provided in jail" predicted shared interest (RR: 5.36; CI: 2.52-11.40; p < .01). For jail administrators, offering other vaccines was 3 times (CI:1.49-6.01; p < .01) and employing a nurse 1.65 times more likely (CI: 1.20-2.28; p < .01) to predict interest in collaborating to offer HPV vaccination. Open-ended responses indicated that managing linkages and stakeholder investment were areas of emphasis where collaborations to provide vaccinations in the jails had been previously implemented. CONCLUSIONS Interest in jail-LHD partnerships to provide HPV vaccinations in jails exists in the Midwest but will require building-out existing programs and linkages and identifying and strengthening shared values, goals, and benefits at all levels.
Collapse
Affiliation(s)
- Amanda Emerson
- School of Nursing and Health Studies, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO, 64108, USA.
| | - Molly Allison
- College of Veterinary Medicine, Kansas State University, Manhattan, KS, 66506, USA
| | - Lisa Saldana
- Oregon Social Learning Center, 10 Shelton McMurphey Blvd., Eugene, Oregon, 97401, USA
| | - Patricia J Kelly
- Jefferson School of Nursing, Thomas Jefferson University, Center City Campus, 901 Walnut Street, 8th Floor, Philadelphia, PA, 19107, USA
| | - Megha Ramaswamy
- Department of Population Health, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
| |
Collapse
|
5
|
Wallace-Brodeur R, Li R, Davis W, Humiston S, Albertin C, Szilagyi PG, Rand CM. A quality improvement collaborative to increase human papillomavirus vaccination rates in local health department clinics. Prev Med 2020; 139:106235. [PMID: 32800972 DOI: 10.1016/j.ypmed.2020.106235] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Revised: 08/03/2020] [Accepted: 08/06/2020] [Indexed: 10/23/2022]
Abstract
Human papillomavirus (HPV) vaccination rates are well below the Healthy People 2020 goal of 80%. Vaccinating in settings other than primary care, such as local health departments (LHDs), may help achieve higher HPV immunization rates. We tested the effect of a quality improvement (QI) collaborative to reduce missed opportunities (MOs) for HPV vaccine in LHDs. Between 2016 and 2019, we conducted four consecutive cohorts of a virtual QI collaborative at 24 LHDs across multiple states. Participants were trained on topics including how to provide an effective recommendation for HPV vaccine, strategies to reduce MOs, and motivational interviewing. Throughout the 6-month project implementation, LHDs tested strategies to reduce MOs through Plan-Do-Study-Act cycles, performed chart reviews to identify and characterize MOs, and received feedback reports to assess progress on MOs. HPV vaccination rates were assessed pre- and post-intervention. LHDs reduced MOs for HPV vaccine in all four cohorts with aggregated data showing a 25.3 percentage point reduction in MOs. Modified Poisson regression analysis found a 44% reduction in the relative risk of missing the opportunity for an HPV vaccine at a visit (RR = 0.56, 0.46-0.68, p < .001). This project shows that strategies effective in reducing MO for HPV vaccine in primary care settings are also effective in LHD settings. Training LHD staff on these strategies may help the U.S. approach national goals for HPV vaccine coverage.
Collapse
Affiliation(s)
- Rachel Wallace-Brodeur
- The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, United States of America.
| | - Rui Li
- Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochetester, NY, United States of America
| | - Wendy Davis
- The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, United States of America
| | - Sharon Humiston
- The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, United States of America; Universtiy of Missouri-Kansas City School of Medicine, Kansas City, MO, United States of America
| | - Christina Albertin
- Mattel Children's Hospital, University of California at Los Angeles, Los Angeles, CA, United States of America
| | - Peter G Szilagyi
- Mattel Children's Hospital, University of California at Los Angeles, Los Angeles, CA, United States of America
| | - Cynthia M Rand
- Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochetester, NY, United States of America
| |
Collapse
|
6
|
Emerson A, Allison M, Kelly PJ, Ramaswamy M. Barriers and facilitators of implementing a collaborative HPV vaccine program in an incarcerated population: A case study. Vaccine 2020; 38:2566-2571. [PMID: 32046888 DOI: 10.1016/j.vaccine.2020.01.086] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2019] [Revised: 01/27/2020] [Accepted: 01/28/2020] [Indexed: 01/29/2023]
Abstract
BACKGROUND Men and women in county jails make up a population that is difficult to reach with traditional preventive health interventions. Collaborations between local health departments and county jails represent an opportunity to enhance public health by reaching a vulnerable population with services like vaccinations. The objective of this study was to coordinate planning and implementation of a collaborative program between a local health department (HD) and a county jail to offer human papillomavirus (HPV) vaccinations to adolescents (ages 10-17) and young adults (ages 18-26) in the jail and to identify facilitators and barriers to inform future program development. METHODS A county-municipal jail and a local HD in Kansas participated. A case study method was employed based on data collected from a focus group, telephone interviews, and site observations, September 2016 to December 2017. Data were coded using codes roughly drawn from the consolidated framework for implementation research (CFIR). Codes were then consolidated into themes related to barriers and facilitators. RESULTS No adults were vaccinated; two juveniles were vaccinated. Barriers to a collaborative program to offer HPV vaccine to young adults arose in two areas: constrained resources and divergent organizational cultures and priorities. Barriers to offering HPV vaccinations to juveniles in the jail included parental consent and the unpredictable, often brief duration of juvenile detentions. A shared commitment to offering HPV vaccination services by leaders and staff in the two agencies was a key facilitator. CONCLUSION Finding ways to leverage leadership and staff buy-in and address specific barriers of constrained resources and divergent culture and priorities merits close attention, since partnerships between jails and local HD have potential to increase HPV vaccination rates in an overlooked population and advance public health.
Collapse
Affiliation(s)
- Amanda Emerson
- University of Missouri-Kansas City, School of Nursing and Health Studies, 2464 Charlotte St, Kansas City, MO 64108, USA.
| | - Molly Allison
- University of Kansas School of Medicine, 3901 Rainbow Blvd, Kansas City, KS 66160, USA.
| | - Patricia J Kelly
- University of Missouri-Kansas City, School of Nursing and Health Studies, 2464 Charlotte St, Kansas City, MO 64108, USA.
| | - Megha Ramaswamy
- University of Kansas School of Medicine, 3901 Rainbow Blvd, Kansas City, KS 66160, USA.
| |
Collapse
|